Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?
Saved in:
| Title: | Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? |
|---|---|
| Authors: | Kobayashi B; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA., Cook IA; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA.; d Department of Bioengineering , University of California Los Angeles , Los Angeles , CA , USA., Hunter AM; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA., Minzenberg MJ; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA., Krantz DE; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA., Leuchter AF; a David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine , University of California Los Angeles , Los Angeles , CA , USA.; c Neuromodulation Division , Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles , Los Angeles , CA , USA. |
| Source: | International review of psychiatry (Abingdon, England) [Int Rev Psychiatry] 2017 Apr; Vol. 29 (2), pp. 98-114. Date of Electronic Publication: 2017 Mar 31. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1369-1627 (Electronic) Linking ISSN: 09540261 NLM ISO Abbreviation: Int Rev Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
